Berlin - Delayed Quote EUR

Pharming Group (PHGN.BE)

Compare
0.8475 -0.0290 (-3.31%)
At close: December 13 at 8:08:40 AM GMT+1
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
285,745.0000
245,316.0000
205,622.0000
198,871.0000
212,174.0000
Cost of Revenue
30,304.0000
25,212.0000
17,562.0000
21,142.0000
23,539.0000
Gross Profit
255,441.0000
220,104.0000
188,060.0000
177,729.0000
188,635.0000
Operating Expense
286,599.0000
242,393.0000
178,200.0000
158,721.0000
112,379.0000
Operating Income
-31,158.0000
-22,289.0000
9,860.0000
19,008.0000
76,256.0000
Net Non Operating Interest Income Expense
-3,592.0000
-2,435.0000
-5,378.0000
-6,132.0000
-5,303.0000
Other Income Expense
17,549.0000
12,712.0000
10,505.0000
10,202.0000
-26,859.0000
Pretax Income
-17,201.0000
-12,012.0000
14,987.0000
23,078.0000
44,094.0000
Tax Provision
622.0000
-1,464.0000
1,313.0000
7,082.0000
6,348.0000
Net Income Common Stockholders
-17,823.0000
-10,548.0000
13,674.0000
15,996.0000
37,746.0000
Diluted NI Available to Com Stockholders
-17,823.0000
-10,548.0000
13,674.0000
15,996.0000
37,746.0000
Basic EPS
-0.03
-0.02
0.02
0.02
0.06
Diluted EPS
-0.03
-0.02
0.02
0.02
0.06
Basic Average Shares
651,906.8850
657,020.5210
651,142.8570
642,285.7140
636,268.9290
Diluted Average Shares
720,350.3120
725,463.9480
719,684.2110
709,894.7370
682,737.2800
Total Operating Income as Reported
-14,256.0000
-5,387.0000
18,233.0000
13,561.0000
76,256.0000
Total Expenses
316,903.0000
267,605.0000
195,762.0000
179,863.0000
135,918.0000
Net Income from Continuing & Discontinued Operation
-17,823.0000
-10,548.0000
13,674.0000
15,996.0000
37,746.0000
Normalized Income
-31,085.5080
-21,713.3197
3,563.7982
9,405.7423
61,048.1242
Interest Income
5,373.0000
3,663.0000
85.0000
53.0000
715.0000
Interest Expense
8,831.0000
5,964.0000
5,358.0000
6,091.0000
5,944.0000
Net Interest Income
-3,592.0000
-2,435.0000
-5,378.0000
-6,132.0000
-5,303.0000
EBIT
-8,370.0000
-6,048.0000
20,345.0000
29,169.0000
50,038.0000
EBITDA
7,556.0000
9,877.0000
33,533.0000
48,779.0000
58,352.0000
Reconciled Cost of Revenue
30,304.0000
18,443.0000
11,528.0000
7,417.0000
16,369.0000
Reconciled Depreciation
15,926.0000
15,925.0000
13,188.0000
19,610.0000
8,314.0000
Net Income from Continuing Operation Net Minority Interest
-17,823.0000
-10,548.0000
13,674.0000
15,996.0000
37,746.0000
Total Unusual Items Excluding Goodwill
17,874.0000
12,715.0000
11,081.0000
9,508.0000
-27,221.0000
Total Unusual Items
17,874.0000
12,715.0000
11,081.0000
9,508.0000
-27,221.0000
Normalized EBITDA
-10,318.0000
-2,838.0000
22,452.0000
39,271.0000
85,573.0000
Tax Rate for Calcs
0.0003
0.0001
0.0001
0.0003
0.0001
Tax Effect of Unusual Items
4,611.4920
1,549.6803
970.7982
2,917.7423
-3,918.8758
12/31/2020 - 10/21/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade